Last reviewed · How we verify
CX-011
At a glance
| Generic name | CX-011 |
|---|---|
| Sponsor | CarthroniX, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CX-011 CI brief — competitive landscape report
- CX-011 updates RSS · CI watch RSS
- CarthroniX, Inc. portfolio CI